EUTECNIQAtlas

Every page of EUTECNIQ on one mapArrow keys move through results · Enter opens · Esc closes

Supplements A–Z Vitamin Sources: 3

Vitamin C

Also called: ascorbic acid, L-ascorbic acid, sodium ascorbate, calcium ascorbate, ascorbate

L-ascorbic acid, a water-soluble vitamin that humans cannot synthesize, so it must come from the diet; it is required to make collagen, L-carnitine and certain neurotransmitters. Sources include citrus fruits, red and green peppers, kiwifruit, broccoli, strawberries and Brussels sprouts.

Category
Vitamin
Forms
Ascorbic acid (most common); sodium, calcium and other mineral ascorbates
Strongest evidence
A Strong
Reviewed
2026-10-28

Class 1 Well studied in people. A 2017 Cochrane review included 8 RCTs (15,445 participants randomized) of vitamin C as a single-nutrient supplement versus placebo or no intervention for at least 3 months. [2]

Fact-checked 2026-10-28 · How this guide is made

Education, not medical advice. These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure or prevent any disease, or to replace any medication or medical advice. EUTECNIQ sells no supplements today, and this page links to no product. Supplements can interact with medicines; ask a doctor or pharmacist before use, especially in pregnancy, while breastfeeding, before surgery or for a child.

Evidence

What research has studied

Grades describe the human evidence in the cited sources, not a recommendation. A means consistent randomized trials; X means good trials found no effect.

6 topics studied4 body areas · strongest grade A

A consistent trialsB some positive trialsC limited human evidenceD lab or animal onlyX no effect in good trials

From the table below Each topic in the table is placed on the part of the body it names, colored by its strongest grade. Tap an area, or open a line in the list, to see its topics. The map shows what was studied, not what Vitamin C does: a C or X area is not evidence of benefit. All 1,071 findings on one body map.
Topics studied for Vitamin C, evidence grade and finding
Topic studiedGradeWhat the evidence shows
Common cold incidenceXA 2013 Cochrane review of placebo-controlled trials using at least 200 mg/day found regular use did not reduce colds in the general community (RR 0.97; 10,708 participants); in 5 trials of 598 marathon runners, skiers and soldiers, it roughly halved cold risk (RR 0.48). [3]
Common cold durationAIn the 2013 Cochrane review, regular use modestly shortened colds by 8% in adults and 14% in children; taking vitamin C after symptoms began had no consistent effect on duration or severity. [3]
CancerXPhysicians' Health Study II (500 mg/day, mean 8 years) and the Women's Antioxidant Cardiovascular Study (500 mg/day, mean 9.4 years) found no effect on total cancer; most randomized trials show no effect on cancer risk. [1]
Cardiovascular diseaseXThe Women's Antioxidant Cardiovascular Study (8,171 women, 500 mg/day, 9.4 years) and Physicians' Health Study II (500 mg/day, 8 years) found no effect on major cardiovascular events. [1]
Age-related macular degeneration (AMD)CIn AREDS (3,597 people, 500 mg with other antioxidants, 6.3 years) high-risk participants had 28% lower risk of advanced AMD, but evidence does not show vitamin C alone affects AMD risk. [1]
CataractsXAREDS participants did not have a significantly lower risk of developing cataracts or cataract progression; a Swedish cohort linked about 1,000 mg/day supplements to 25% higher cataract extraction risk. [1]
Amounts

Amounts studied and limits

Amounts used in research, not dosing advice. Products differ in form and strength; a clinician can advise on an individual dose.

  • RDA, adults 19+: men 90 mg; women 75 mg; pregnancy 85 mg; lactation 120 mg. People who smoke need 35 mg/day more than nonsmokers. [1]
  • Trial amounts: at least 200 mg/day (Cochrane common-cold review); 500 mg/day (Physicians' Health Study II; Women's Antioxidant Cardiovascular Study); 500 mg with other antioxidants (AREDS). [1]

Upper limits

  • UL, adults 19+ (including pregnancy and lactation): 2,000 mg/day, applying to both food and supplement intakes; it does not apply to individuals receiving vitamin C for medical treatment. [1]
Safety

Safety and side effects

  • Liver (NIH LiverTox)
    Score E
    A: well known causeE: unlikely cause

    LiverTox likelihood score E (unlikely cause of clinically apparent liver injury), chapter updated 2021-05-27 …

    Details and sources
  • Pregnancy and breastfeeding
    RDA in pregnancy 85 mg (age 19+) and 80 mg (14–18); lactation 120 mg and 115 mg. UL 2,000 mg (19+) and 1,800 mg (14–18) in pregnancy and lactation.

    1 statement in the profile.

    Details and sources
  • Interactions with medicines
    2 listed

    Chemotherapy and radiation therapy; Simvastatin with niacin

    Details and sources
  • Cancer evaluations (IARC, NTP)
    1 found

    Each names the exact material tested, which may differ from a supplement.

    Details and sources
  • FDA new dietary ingredient notifications
    11 on FDA's list

    FDA does not approve dietary supplements. Each entry is one party's filing.

    Details and sources
  • Dose in official monographs
    None found

    No published information found in the sources checked.

    Details and sources
  • High doses can cause diarrhea, nausea, abdominal cramps and other gastrointestinal disturbances. [1]
  • It is not clear whether vitamin C plays a role in kidney stones; the best evidence concerns people with pre-existing hyperoxaluria. [1]
  • In people with hereditary hemochromatosis, chronic high-dose use could exacerbate iron overload and cause tissue damage. [1]
  • Deficiency causes scurvy, which can appear within 1 month of intake below about 10 mg/day and is fatal if untreated. At-risk groups include smokers and people exposed to secondhand smoke, and people with limited food variety or malabsorption. [1]
Interactions

Interactions

Vitamin C
From the table below 2 interactions the sources name. Tap one to read what happens. A line means a documented or possible interaction, not its size.
Known interactions of Vitamin C
WithWhat happens
Chemotherapy and radiation therapySome data indicate antioxidants might protect tumor cells from radiation and agents such as cyclophosphamide and doxorubicin; it is unclear whether oral vitamin C changes concentrations enough. Patients should consult their oncologist. [1]
Statins with niacin (simvastatin/niacin)Vitamin C with other antioxidants may attenuate the rise in HDL cholesterol from combination niacin/simvastatin; lipid levels should be monitored. [1]

Tell a pharmacist or doctor about every supplement you take. All documented interactions in this hub.

Quality

Identity, quality and standardization

  • Ascorbic acid in supplements has equivalent bioavailability to naturally occurring ascorbic acid in foods; comparative studies led authors to conclude simple ascorbic acid is the preferred source of supplemental vitamin C. [1]
Regulation

Regulatory status

  • US: available in dietary supplements and added to some breakfast cereals. The FDA Daily Value is 90 mg for adults and children age 4 years and older. [1]
Profile

Safety, quality and supply profile

Fourteen questions a careful buyer, formulator or clinician would ask, each answered only from a cited source (checked 2026-10-29). If our sources do not answer a question, we say so.

Compounds responsible

Compounds the sources name as the main or characteristic actives.

  • L-ascorbic acid (most common supplement form), sodium, calcium and other mineral ascorbates Water-soluble vitamin (L-ascorbic acid and its salts) [P1]

US status

What FDA's published records show. FDA does not approve dietary supplements.

  • FDA's published NDI notification list has 11 entries naming vitamin C or an ascorbate (all as part of multi-ingredient products or salts) (earliest NDI 494 submitted 2007-12-03; most recent NDI 1188 submitted 2020-12-02). Each entry is one party's notification; the list gives the date of FDA's response letter but not what it said. [P2]

Cancer evaluations (IARC and NTP)

Evaluations name the exact material tested, which may differ from a supplement.

  • NTP TR-247 (March 1983), L-ascorbic acid in feed: under the conditions of the bioassay, not carcinogenic for male or female F344/N rats or B6C3F1 mice. [P3]
  • Vitamin C (ascorbic acid) does not appear in the IARC Monographs list of classifications (checked 2026-10-29). [P4]

Liver (NIH LiverTox)

  • LiverTox likelihood score E (unlikely cause of clinically apparent liver injury), chapter updated 2021-05-27; very high doses have been reported to cause transient serum ALT elevations but not clinically apparent liver injury with jaundice. [P5]

Interactions with medicines

  • Chemotherapy and radiation therapy: Some data suggest antioxidants might protect tumor cells from radiation and agents such as cyclophosphamide, chlorambucil, carmustine, busulfan, thiotepa and doxorubicin; it is unclear whether oral supplements change vitamin C levels enough to matter. Patients should consult their oncologist. [P1]
  • Simvastatin with niacin: Vitamin C with other antioxidants may attenuate the rise in HDL cholesterol from niacin/simvastatin; lipid levels should be monitored. [P1]

Alcohol

  • No published information found in the sources checked.

Interactions with other herbs and supplements

  • No published information found in the sources checked.

Adulteration and substitution

  • No published information found in the sources checked.

What a certificate of analysis should cover

Tests a quality specification for this material would include, with the reason for each.

  • Identity: at least one appropriate test or examination of each component that is a dietary ingredient — Required by 21 CFR 111.75(a)(1)(i) for every dietary-ingredient component; an exemption may be requested by petition under 21 CFR 10.30. [P6]

Supply and conservation

  • No published information found in the sources checked.

Absorption in people

  • 70% to 90% of vitamin C is absorbed at intakes of 30 to 180 mg/day; above 1 g/day absorption falls to less than 50%. Oral ascorbic acid 1.25 g/day gives a mean peak plasma level of 135 micromoles/L, and modeling of 3 g every 4 hours predicts a peak of only 220 micromoles/L. [P1]
  • Supplemental ascorbic acid has bioavailability equivalent to naturally occurring ascorbic acid in foods; one study found no differences in plasma levels or urinary excretion among ascorbic acid, a calcium ascorbate product and ascorbic acid with bioflavonoids. [P1]

Formulations studied to change absorption

Human data only.

  • No published information found in the sources checked.

Dose in official monographs

As the monograph states it, for its jurisdiction; not personal advice.

  • No published information found in the sources checked.

Pregnancy and breastfeeding

  • RDA in pregnancy 85 mg (age 19+) and 80 mg (14–18); lactation 120 mg and 115 mg. UL 2,000 mg (19+) and 1,800 mg (14–18) in pregnancy and lactation. [P1]

Sources for this profile

  1. NIH Office of Dietary Supplements. Vitamin C: Fact Sheet for Health Professionals (updated July 31, 2025), 2025-07-31. ods.od.nih.gov
  2. FDA. Submitted 75-Day Premarket Notifications for New Dietary Ingredients (list dated July 9, 2026), 2026-07-09. fda.gov
  3. NTP. TR-247: Carcinogenesis Bioassay of L-Ascorbic Acid (Vitamin C) in F344/N Rats and B6C3F1 Mice (Feed Study) (March 1983), 1983-03. ntp.niehs.nih.gov
  4. IARC Monographs. Agents Classified by the IARC Monographs: List of Classifications (accessed 2026-10-29), 2026-10-29. monographs.iarc.who.int
  5. NIH LiverTox (NIDDK). Vitamin C (Last Update: 2021-05-27), 2021-05-27. ncbi.nlm.nih.gov
  6. eCFR. 21 CFR 111.75, What must you do to determine whether specifications are met? (up to date as of 10/23/2026), 2026-10-23. ecfr.gov
Sources

Sources

  1. NIH Office of Dietary Supplements. Vitamin C: Fact Sheet for Health Professionals (updated July 31, 2025), 2025-07-31. ods.od.nih.gov
  2. Al-Khudairy L, et al. Vitamin C supplementation for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev 2017;3(3):CD011114 (PMID 28301692), 2017-03-16. pubmed.ncbi.nlm.nih.gov
  3. Hemilä H, Chalker E. Vitamin C for preventing and treating the common cold. Cochrane Database Syst Rev 2013;(1):CD000980 (PMID 23440782), 2013-01-31. pubmed.ncbi.nlm.nih.gov
A
Consistent results from several randomized trials or a systematic review of them
B
Some positive randomized trials, but small, short, few or inconsistent
C
Limited human evidence: single small trials, observational data or mixed results
D
Laboratory or animal evidence only; not shown in people
X
Well-designed human trials found no meaningful effect

More in vitamin: Benfotiamine · Biotin · Folate (folic acid) · Methylfolate (L-5-MTHF) · Niacin (vitamin B3) · Nicotinamide riboside · Pantothenic acid (vitamin B5) · Riboflavin (vitamin B2) · All entries A–Z · How to judge a supplement

Health information notice

These statements have not been evaluated by the Food and Drug Administration. Nothing on this site is intended to diagnose, treat, cure or prevent any disease. The information is for general education only. It is not medical advice and does not replace advice, diagnosis or treatment from a qualified health professional, or any medication a clinician has prescribed.

Do not start, stop or change any medicine, supplement or herbal product because of something you read here. Talk to your doctor or pharmacist first, especially if you are pregnant or breastfeeding, have a medical condition, take any medicines, are preparing for surgery, or are caring for a child. Research findings, traditional uses and safety data are reported as their sources state them; they are not recommendations or claims about any product. If you think you may have a medical emergency, call your doctor or 911 at once.

EUTECNIQ Sciences sells no supplements or health products today and receives nothing from any product or ingredient mentioned on this site; any commercial interest it later has in an ingredient will be stated on that ingredient’s page.

Ready to check what you take?

Free tools built on published reference values, each with its sources and its limits. Your lists stay in your browser.